Unité de Recherche sur les Maladies Infectieuses et Tropicales Émergentes, URMITE CNRS-IRD, UMR 6236, Méditerranée Infection, Faculté de Médecine et de Pharmacie, Aix-Marseille Université, Marseille, France; Laboratoire Microbiologie, CHU de Constantine, Constantine, Algeria.
Laboratoire de Biologie et Environnement, Faculté des Sciences de la Nature et de la Vie, Université des Frères Mentouri Constantine 1, Constantine, Algeria.
J Glob Antimicrob Resist. 2019 Mar;16:125-129. doi: 10.1016/j.jgar.2018.08.019. Epub 2018 Sep 11.
Carbapenemase-producing, or carbapenem-resistant, Enterobacteriaceae are an emerging threat to human and animal health because they are resistant to many of the last-line antimicrobials available for treatment of infection. The aim of this study was to analyse the antimicrobial resistance patterns and their encoding genes of Proteus mirabilis isolated in Constantine, Algeria.
A total of 108 Proteus, Morganella and Providencia (PMP) strains were isolated from a large variety of clinical specimens at University Hospital of Constantine in Algeria. Isolates were identified using the API 20E system and matrix-assisted laser desorption/ionisation time-of-flight mass spectrometry (MALDI-TOF/MS). Diagnostic accuracy was determined by independent comparison of each method to phylogenetic analysis based on 16S rRNA gene sequencing. Antimicrobial susceptibility was determined by the standard disk diffusion and Etest methods. The presence of antimicrobial resistance genes was screened for by PCR amplification and sequencing.
A total of 72 PMP strains were multidrug-resistant (MDR). Among them, one P. mirabilis isolate was resistant to imipenem with a minimum inhibitory concentration (MIC) of ≥12μg/mL. PCR and sequencing showed the presence of various antimicrobial resistance genes, including bla, bla, bla, bla, bla, aadA1, aadA2, armA, aac(6')-Ib, aac(6')-Ib-cr, aac(3)-Ia and ant(2″)-I, forming different resistance profiles. Moreover, the bla gene was detected in the imipenem-resistant P. mirabilis strain.
In this study, a MDR P. mirabilis isolate harbouring the bla, armA 16S rRNA methylase and aac(6)-Ib-cr genes was found for the first time in Algeria.
产碳青霉烯酶或碳青霉烯耐药的肠杆菌科细菌对人类和动物健康构成了新的威胁,因为它们对许多可供治疗感染的最后一线抗菌药物具有耐药性。本研究旨在分析在阿尔及利亚君士坦丁分离的奇异变形杆菌的抗菌药物耐药模式及其编码基因。
从阿尔及利亚君士坦丁大学医院的各种临床标本中分离出 108 株变形杆菌、摩根菌和普罗威登斯菌(PMP)。使用 API 20E 系统和基质辅助激光解吸/电离飞行时间质谱(MALDI-TOF/MS)进行鉴定。通过每种方法与基于 16S rRNA 基因测序的系统发育分析的独立比较来确定诊断准确性。通过标准纸片扩散和 Etest 方法测定抗菌药物敏感性。通过 PCR 扩增和测序筛选抗菌药物耐药基因的存在。
共有 72 株 PMP 菌株为多药耐药(MDR)。其中,一株奇异变形杆菌对亚胺培南的最小抑菌浓度(MIC)≥12μg/mL 表现出耐药性。PCR 和测序显示存在各种抗菌药物耐药基因,包括 bla、bla、bla、bla、bla、aadA1、aadA2、armA、aac(6')-Ib、aac(6')-Ib-cr、aac(3)-Ia 和 ant(2″)-I,形成不同的耐药谱。此外,在耐亚胺培南的奇异变形杆菌株中检测到 bla 基因。
在这项研究中,首次在阿尔及利亚发现一株携带 bla、armA 16S rRNA 甲基化酶和 aac(6)-Ib-cr 基因的 MDR 奇异变形杆菌。